gsk and other pharmas will do well out of their vaccine production regardless of cancelations - they will only lose money on vaccines not yet produced and shipped. (cancellation of unfilled orders) they will make a motsa out of the balance and make even more when the virus mutates and the vaccv has to be re created. The slow production-delivery in the face of another potentially more lethal pandemic will help anti-viral market no end.Antiviral strategies will be strengthened.
did the telegraph send a reply?
BTA Price at posting:
$2.04 Sentiment: LT Buy Disclosure: Held
